Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@BH1377 9
@TickerReport 6
@Clover_Research 4
@OlympiaReport 4
@YuZhu4 3

Recent Tweets for ESPR

BACScoreChanges @BACScoreChanges
#EsperionTherapeutics $ESPR BidaskScore is Downgraded to Held https://t.co/lZKeoDAhWl
July 15th 2019, 11:07pm
TickerReport @TickerReport
Esperion Therapeutics $ESPR Upgraded to Hold by BidaskClub https://t.co/tnPo7tjmiB
July 14th 2019, 5:07am
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Stock Rating Upgraded by BidaskClub https://t.co/1IELvRcS3D
July 14th 2019, 5:07am
ZolmaxNews @ZolmaxNews
Esperion Therapeutics Inc $ESPR Receives $72.89 Average Price Target from Analysts https://t.co/XpfwMcXAJY
July 13th 2019, 1:07pm
dakotafinancial @dakotafinancial
Esperion Therapeutics Inc $ESPR Receives $72.89 Average Price Target from Analysts https://t.co/eHy6KYs8ST
July 13th 2019, 1:07pm
BH1377 @BH1377
@Clover_Research @iamdimitre BTW, I stand corrected on my statement regarding the positive signal for $ESPR with th… https://t.co/5YOg3a6eFh
July 11th 2019, 5:07pm
Gambiste1 @Gambiste1
RT @Clover_Research: @BH1377 You have zero criticisms or concerns for an $ESPR investment?
July 11th 2019, 1:07pm
BH1377 @BH1377
@Clover_Research I have concerns for all my investments, including $ESPR, but you haven't stated any of them, or ba… https://t.co/eWEvU5QrOG
July 11th 2019, 12:07pm
Clover_Research @Clover_Research
@BH1377 You have zero criticisms or concerns for an $ESPR investment?
July 11th 2019, 12:07pm
BH1377 @BH1377
@Clover_Research Why would anyone make that point if they weren't trying to be negative re $ESPR? Given your acknow… https://t.co/zCF0PAoL9r
July 11th 2019, 12:07pm
BH1377 @BH1377
Clover's reply to me regarding my $ESPR comments speaks for itself. Do your homework, read the research, don't jus… https://t.co/QtPuRfA8e1
July 11th 2019, 11:07am
BH1377 @BH1377
@Clover_Research You're bullish on $ESPR prospects, but post negative leaning statements that aren't true? Interes… https://t.co/IBs7l1ld7O
July 11th 2019, 11:07am
BH1377 @BH1377
Read the criteria for $ESPR's CLEAR Outcomes Study...it's designed to succeed; data 2021-22 & results likely better… https://t.co/nqrAwHATCz
July 11th 2019, 11:07am
Clover_Research @Clover_Research
@BH1377 Zetia, in combination with statins, has proved added benefit worthy of coverage. I'm bullish on $ESPR prosp… https://t.co/JO2jY7FSNJ
July 11th 2019, 11:07am
BH1377 @BH1377
The fact is that $ESPR has two new drugs with positive P3 trials in 1000's of patients & both of these drugs are al… https://t.co/rhCAZPLn3f
July 11th 2019, 11:07am
Clover_Research @Clover_Research
$ESPR "statin-intolerance" isn't a market. In fact, true intolerance hardly exists at all. And MDs should reduce do… https://t.co/jTDPeC4hXT
July 11th 2019, 10:07am
fda_tracker @fda_tracker
$ESPR Phase 2 trial w/est Jul completion date NCT03531905: https://t.co/0JYusK5Fov Trial Tracker: https://t.co/aR7q5oJwjn
July 11th 2019, 9:07am
BH1377 @BH1377
@Clover_Research $ESPR's CEO seems to think so. He's bought 10K shares on the open mkt with his own money YTD. His… https://t.co/UWSh3zZU29
July 10th 2019, 2:07pm
Clover_Research @Clover_Research
$ESPR seems very cheap, doesn't it? https://t.co/8aBur1i6Tz
July 10th 2019, 2:07pm
ConsumerFeed @ConsumerFeed
Esperion Therapeutics Inc $ESPR Expected to Post Quarterly Sales of $930,000.00 https://t.co/styaKOftJ7
July 10th 2019, 1:07pm
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Receives $72.89 Consensus Price Target from Brokerages https://t.co/Ig9HEaZOsu
July 9th 2019, 4:07am
OlympiaReport @OlympiaReport
Esperion Therapeutics Inc $ESPR Expected to Post Earnings of -$1.89 Per Share https://t.co/geBJrmg9sj
July 8th 2019, 11:07am
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Expected to Announce Earnings of -$1.89 Per Share https://t.co/zhnyRRZ6kK
July 8th 2019, 11:07am
bbnsnews @bbnsnews
Esperion Therapeutics $ESPR Downgraded by BidaskClub to “Sell” https://t.co/6ADnK8Q6lB
July 7th 2019, 4:07am
AmericanBanking @AmericanBanking
Esperion Therapeutics Inc $ESPR Receives Average Recommendation of “Hold” from Analysts https://t.co/2FPOs1a4qF #stocks
July 6th 2019, 2:07pm
EnterpriseLeade @EnterpriseLeade
Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/RwFP9zxV7b
July 6th 2019, 7:07am
registrarjourn @registrarjourn
Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/sYxoklcqTF
July 6th 2019, 7:07am
dispatchtribune @dispatchtribune
Esperion Therapeutics $ESPR Downgraded by BidaskClub https://t.co/gwTRiEjyt5
July 6th 2019, 7:07am
AmericanBanking @AmericanBanking
$930,000.00 in Sales Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/lxjmzWLI5W #stocks
July 5th 2019, 4:07am
TickerReport @TickerReport
BidaskClub Lowers Esperion Therapeutics $ESPR to Sell https://t.co/BNh8KYadXF
July 5th 2019, 4:07am
Gambiste1 @Gambiste1
RT @TradeFlags: TD BUY $ESPR at 47.21, Supp 45.58 Resis 51.31 R13 HiLo 45% T1Y 89 buy 1.9 fwdPE -17.2 DIV N/A #Esperion T #stocks #trading…
July 4th 2019, 7:07am
dakotafinancial @dakotafinancial
Insider Buying: Esperion Therapeutics Inc $ESPR CEO Purchases 5,000 Shares of Stock https://t.co/afeG0BY9Fv
July 4th 2019, 5:07am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $ESPR? The Short Ratio is 11.3% https://t.co/A5AE9594PW
July 4th 2019, 12:07am
TradeFlags @TradeFlags
TD BUY $ESPR at 47.21, Supp 45.58 Resis 51.31 R13 HiLo 45% T1Y 89 buy 1.9 fwdPE -17.2 DIV N/A #Esperion T #stocks… https://t.co/b9lVKEG8rM
July 4th 2019, 12:07am
AmericanBanking @AmericanBanking
-$1.89 EPS Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/tjaqR4mXjr #stocks
July 3rd 2019, 9:07am
TickerReport @TickerReport
Insider Buying: Esperion Therapeutics Inc $ESPR CEO Purchases 5,000 Shares of Stock https://t.co/XiEWUmj2oM
July 3rd 2019, 4:07am
OlympiaReport @OlympiaReport
Timothy M. Mayleben Purchases 5,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/2aXUbT4R4u
July 3rd 2019, 4:07am
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR vs. Aimmune Therapeutics $AIMT Head-To-Head Contrast https://t.co/IhvPnpEH6V
July 3rd 2019, 3:07am
TheMarketsDaily @TheMarketsDaily
FY2020 Earnings Forecast for Esperion Therapeutics Inc Issued By Jefferies Financial Group $ESPR https://t.co/L8zt1mnplW
July 3rd 2019, 2:07am
YuZhu4 @YuZhu4
RT @haodongvli: $BHVN $ESPR: both CEOs bought 5K shares of their own stocks on secondary market, confidence game!
July 2nd 2019, 4:07pm
haodongvli @haodongvli
$BHVN $ESPR: both CEOs bought 5K shares of their own stocks on secondary market, confidence game!
July 2nd 2019, 3:07pm
YuZhu4 @YuZhu4
RT @BH1377: Second time this year $ESPR's CEO bought 5K shares with money out of his own pocket...not stock grants / awards or part of his…
July 2nd 2019, 1:07pm
YuZhu4 @YuZhu4
RT @haodongvli: $ESPR it is going to be a triple digits stock in 2020, agree with its CEO who bought at $46 yesterday
July 2nd 2019, 1:07pm
MarginCall3 @MarginCall3
@jonnajarian hey, what’s up with the huge spike in $60 options call buying for $ESPR?
July 2nd 2019, 11:07am
haodongvli @haodongvli
$ESPR it is going to be a triple digits stock in 2020, agree with its CEO who bought at $46 yesterday
July 2nd 2019, 10:07am
StockBrain99 @StockBrain99
Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/nMGbnIVgWG
July 2nd 2019, 10:07am
StockBrain2010 @StockBrain2010
Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/SAoDsuuTOM
July 2nd 2019, 10:07am
StockBrain99 @StockBrain99
Tuesday ALL ACTIVE BUY STOP ORDERS ABOVE THE MARKET 4 TODAY already bot past 10 minutes $ESPR #stocks #news… https://t.co/vWXQ201joE
July 2nd 2019, 10:07am
MarginCall3 @MarginCall3
CEO of Esperion $ESPR just bought 5,000 shares at market price Also, there is a huge options call buying at $60 st… https://t.co/26kd3lqr8u
July 2nd 2019, 10:07am
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Downgraded by ValuEngine to “Buy” https://t.co/DDQIyRzZ9i
July 2nd 2019, 6:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.